Patents by Inventor Pascale Briand

Pascale Briand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Viral recombinant vectors for expression in muscle cells
    Patent number: 6743623
    Abstract: Non-replicable viral recombinant vectors which are recognizable by muscle cell receptors, and furthermore modified by an inserted nucleic acid coding for a polypeptide sequence to be expressed in the muscle cells, are used to obtain a composition for treating muscle cell diseases or disease which, by virtue of their location in the body are accessible to the production of expression. A method for producing said vectors and their use in pharmaceutical compositions are also described.
    Type: Grant
    Filed: December 6, 1999
    Date of Patent: June 1, 2004
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Michel Perricaudet, Pascale Briand, Leslie Stratford-Perricaudet
  • Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
    Publication number: 20030086907
    Abstract: The present invention concerns utilization of defective recombinant viruses containing an inserted gene for preparation of a pharmaceutical composition for treatment of ocular pathologies.
    Type: Application
    Filed: December 20, 2002
    Publication date: May 8, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Pascale Briand, Michel Perricaudet
  • VIRAL RECOMBINANT VECTORS FOR EXPRESSION IN MUSCLE CELLS
    Publication number: 20020122789
    Abstract: Non-replicatable viral recombinant vectors which are recognizable by muscle cell receptors, and furthermore modified by an insertion nucleic acid coding for a polypeptide sequence to be expressed in said muscle cells, are used to obtain a drug for treating muscle cell diseases or diseases which, by virtue of their location in the body, are accessible to the products of the expression of the above mentioned nucleotide sequence, as secreted by said muscle cells. A method for producing said vectors, vectors such as those described above, and their use in pharmaceutical compositions are also provided.
    Type: Application
    Filed: December 6, 1999
    Publication date: September 5, 2002
    Inventors: MICHEL PERRICAUDET, PASCALE BRIAND, LESLIE STRATFORD-PERRICAUDET
  • Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
    Publication number: 20020068052
    Abstract: The present invention concerns utilization of defective recombinant viruses containing an inserted gene for preparation of a pharmaceutical composition for treatment of ocular pathologies.
    Type: Application
    Filed: November 13, 2001
    Publication date: June 6, 2002
    Applicant: Aventis Pharma S.A.
    Inventors: Pascale Briand, Michel Perricaudet
  • RECOMBINANT ADENOVIRUSES AND USE THEREOF IN GENE THERAPY FOR TREATING EYE DISEASES
    Publication number: 20020064870
    Abstract: The present invention concerns utilization of defective recombinant viruses containing an inserted gene for preparation of a pharmaceutical composition for treatment of ocular pathologies.
    Type: Application
    Filed: May 28, 1998
    Publication date: May 30, 2002
    Inventors: PASCALE BRIAND, MICHEL PERRICAUDET
  • Regulation of cellular apoptosis using modulators of &bgr;-AR receptors
    Patent number: 6333359
    Abstract: The invention concerns the use of &bgr;2-adrenergic modulators for regulating cellular apoptosis.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: December 25, 2001
    Assignee: Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Jean-Gérard Guillet, Claudine Andre, Pascale Briand
  • Viral recombinant vectors for expression in muscle cells
    Patent number: 6099831
    Abstract: Non-replicatable viral recombinant vectors which are recognizable by muscle cell receptors, and furthermore modified by an insertion nucleic acid coding for a polypeptide sequence to be expressed in said muscle cells, are used to obtain a drug for treating muscle cell diseases or diseases which, by virtue of their location in the body, are accessible to the products of the expression of the above-mentioned nucleotide sequence, as secreted by said muscle cells. A method for producing said vectors, vectors such as those described above, and their use in pharmaceutical compositions are also provided.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: August 8, 2000
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Michel Perricaudet, Pascale Briand, Leslie Stratford-Perricaudet